|
|
Article: "Cancer Vaccine Developments to 2011" by Espicom Healthcare Intelligence September 2007.
- Article from:
- M2 Presswire
- Article date:
- September 19, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-19 September 2007-MarketResearch.com: "Cancer Vaccine Developments to 2011" by Espicom Healthcare Intelligence September 2007(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:18092007
Who are the players and products in the race to launch? This report critically assesses the candidates in their wider market context, providing a complete review of the market and its likely development to 2013.
The launch of Sanofi Pasteur MSD's Gardasil and GSK s Cervarix has propelled cancer vaccines from research obscurity to a key area of commercial and clinical interest. But can the sector capitalise on these gains and really fulfil its promise?
...